Hims & Hers Health Inc (NYSE:HIMS) has a beta value of 1.59 and has seen 23.44 million shares traded in the last trading session. The company, currently valued at $7.99B, closed the last trade at $35.95 per share which meant it gained $1.56 on the day or 4.54% during that session. The HIMS stock price is -103.0% off its 52-week high price of $72.98 and 68.85% above the 52-week low of $11.20.
The consensus among analysts is that Hims & Hers Health Inc (HIMS) is Buy stock at the moment, with a recommendation rating of 2.47. 0 analysts rate the stock as a Sell, while 1 rate it as Overweight. 5 out of 13 have rated it as a Hold, with 7 advising it as a Buy. 0 have rated the stock as Underweight. The expected earnings per share for the stock is 0.21.
Hims & Hers Health Inc (NYSE:HIMS) trade information
Sporting 4.54% in the green in last session, the stock has traded in the red over the last five days, with the highest price hit on recent trading when the HIMS stock price touched $35.95 or saw a rise of 22.44%. Year-to-date, Hims & Hers Health Inc shares have moved 48.68%, while the 5-day performance has seen it change -20.27%. Over the past 30 days, the shares of Hims & Hers Health Inc (NYSE:HIMS) have changed -14.81%.
Wall Street analysts have a consensus price target for the stock at $25.5, which means that the shares’ value could drop -40.98% from current levels. The projected low price target is $21.0 while the price target rests at a high of $68.0. In that case, then, we find that the current price level is -89.15% off the targeted high while a plunge would see the stock lose 41.59% from current levels.
Hims & Hers Health Inc (HIMS) estimates and forecasts
The company’s shares have gained 146.06% over the past 6 months. Revenue growth from the last financial year stood is estimated to be 57.02%.
10 analysts offering their estimates for the company have set an average revenue estimate of 534.97M for the current quarter. 10 have an estimated revenue figure of 564.16M for the next ending quarter. Year-ago sales stood 278.17M and 315.65M respectively for this quarter and the next, and analysts expect sales will grow by 92.32% for the current quarter and 57.02% for the next.
If we evaluate the company’s growth over the last 5-year and for the next 5-year period, we find that annual earnings growth was 17.22% over the past 5 years. Earnings growth for 2025 is a modest 9.43% while over the next 5 years, the company’s earnings are expected to increase by 31.05%.
HIMS Dividends
Hims & Hers Health Inc is expected to release its next earnings report in April this year, and investors are excited at the prospect of better dividends despite the company’s debt issue.
Hims & Hers Health Inc (NYSE:HIMS)’s Major holders
The top two institutional holders are VANGUARD GROUP INC with over 16.47 million shares worth more than $332.55 million. As of 2024-06-30, VANGUARD GROUP INC held 7.7166% of shares outstanding.
The other major institutional holder is BLACKROCK INC., with the holding of over 14.57 million shares as of 2024-06-30. The firm’s total holdings are worth over $294.25 million and represent 6.8278% of shares outstanding.
Also the top two Mutual Funds that are holding company’s shares are iShares Core S&P Smallcap ETF and Vanguard Total Stock Market Index Fund . As of Dec 31, 2024 , the former fund manager holds about 5.76% shares in the company for having 12.32 shares of worth $443.02 million while later fund manager owns 5.31 shares of worth $190.94 million as of Sep 30, 2024 , which makes it owner of about 2.48% of company’s outstanding stock.
